Projects funded by the NCN
Selective modulation of PPARγ signaling as a new therapeutic strategy for Alzheimer's disease
2022/45/N/NZ7/01418
Keywords:
neuroprotection Alzheimer's Disease PPAR gamma apoptosis autophagy epigenetics miRNA lncRNA
Descriptors:
- NZ3_5: Molecular neurobiology
- NZ7_12: Prevention of human diseases
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 21 - announced on 2022-03-28
Amount awarded: 210 000 PLN
Project start date (Y-m-d): 2023-02-02
Project end date (Y-m-d): 2026-02-01
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.